Skip to main content
SpringerLink
Log in

Supra-normal left ventricular ejection fraction in cardiac amyloidosis

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Solomon SD, Vaduganathan M, Claggett L et al (2020) Sacubitril/valsartan across the spectrum of ejection fraction in heart failure. Circulation 141:352–361

    Article  PubMed  Google Scholar 

  2. Butler J, Packer M, Filippatos G et al (2021) Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction. Eur Heart J 43:416

    Article  PubMed Central  Google Scholar 

  3. Packer M, Zannad F, Anker SD (2021) Heart failure and a preserved ejection fraction: a side-by-side examination of the PARAGON-HF and EMPEROR-preserved trials. Circulation 144:1193–1195

    Article  PubMed  Google Scholar 

  4. Donnellan E, Wazni OM, Hanna M et al (2020) Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies. JACC Clin Electrophysiol 6:1118–1127

    Article  PubMed  Google Scholar 

  5. Oghina S, Bougouin W, Bezard M et al (2021) The impact of patients with cardiac amyloidosis in HFpEF trials. JACC Heart Fail 9:169–178

    Article  PubMed  Google Scholar 

Download references

Funding

Belgian American Educational Foundation, Frans van de Werf fund.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH, 44195, USA

    Pieter Martens, Mazen Hanna, Jerry D. Estep & W. H. Wilson Tang

  2. Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

    Jason Valent

Authors
  1. Pieter Martens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mazen Hanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jason Valent
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jerry D. Estep
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. H. Wilson Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. H. Wilson Tang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martens, P., Hanna, M., Valent, J. et al. Supra-normal left ventricular ejection fraction in cardiac amyloidosis. Clin Res Cardiol 112, 441–443 (2023). https://doi.org/10.1007/s00392-022-02043-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-022-02043-w

Search

Navigation